Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 37,545,308
- Total 13F value
- $98,742,458
- Share change
- -2,196,110
- Put/Call ratio
- 1.6%
- SEC-reported price per share
- $2.63
- Number of holders
- 87
- Value change
- -$7,793,831
- Number of buys
- 43
- Number of sells
- 33
- Shares outstanding
- 53,364,241
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2025
Institutions
87
Top holders
10
SCPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 810648105
Recent filing periods:
Ownership snapshot
Top reported holders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
3/4/5
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
11%
Rubric Capital Management LP
8.9%
AIGH Capital Management LLC
7.8%
KING LUTHER CAPITAL MANAGEMENT CORP
5.4%
BlackRock, Inc.
4.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
11%
|
$21,450,729
6,059,528 shares
|
— | 31 Dec 2024 |
| Rubric Capital Management LP |
13F
Company
|
8.9%
|
$16,903,500
4,775,000 shares
|
— | 31 Dec 2024 |
| AIGH Capital Management LLC |
13F
Company
|
7.8%
|
$14,777,259
4,174,367 shares
|
— | 31 Dec 2024 |
| KING LUTHER CAPITAL MANAGEMENT CORP |
13F
Company
|
5.4%
|
$10,117,001
2,857,910 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
4.3%
|
$8,082,433
2,283,173 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4%
|
$7,463,938
2,108,457 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
87
Shares
37,545,308
Rows available
87
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
84
Q1 2025 holders
87
Holder diff
3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend